RecruitingInterventionalPhase 3Last updated Jan 29, 2026

Oxybutynin for Post-surgical Bladder Pain and Urgency

Overview

ClinicalTrials.gov ID: NCT03952299
Lead Sponsor: University of California, DavisOTHER
Brief Summary: Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Study Type: Interventional

Status

Study Record Dates

NCT00224029Completed

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

NCT00224016Completed

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

NCT00224146Completed

Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder

NCT02600715Completed

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository

NCT02865395Terminated

Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms

NCT07081906Completed

Transdermal Versus Oral Oxybutynin in Pediatric OAB